Pharming (PHAR) EBIT (QoQ) (2020 - 2026)
Pharming (PHAR) EBIT (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79,209,777.42% |
| Dec 31, 2025 | -100.00% |
| Sep 30, 2025 | 415,243,001.18% |
| Jun 30, 2025 | 154.02% |
| Mar 31, 2025 | 100.00% |
| Dec 31, 2024 | -310.27% |
| Sep 30, 2024 | 121.10% |
| Jun 30, 2024 | -119,133,053.51% |
| Mar 31, 2024 | -150.95% |
| Dec 31, 2023 | -100.00% |
| Sep 30, 2023 | -100.00% |
| Jun 30, 2023 | 38,790,995.12% |
| Mar 31, 2023 | -148.11% |
| Dec 31, 2022 | 264.10% |
| Sep 30, 2022 | -56.18% |
| Jun 30, 2022 | 535.71% |
| Mar 31, 2022 | 119.14% |
| Dec 31, 2021 | -771.65% |
| Sep 30, 2021 | -115.46% |
| Jun 30, 2021 | 72.25% |